ARCHIVES

Drugs and Targets: EU approves Imbruvica in MCL, CLL

This article is from The Cancer Letter archive.

Vol. 40 No. 40 | October 24, 2014

Download PDF Visit The Full Archive

Related Articles

Seven New Initiatives For NIH Common Fund

February 26, 2010

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990

NCI To Fund Only 30-35% Of Approved Grants Even With $815 Million Construction Slashed

August 20, 1976

NCI Gets Out of the News Business

January 25, 2013

NCI Supercomputer To Be Available To Extramural Scientists

June 8, 1984

Centers Settle Into New Home, Face Old Problem; Five May Lose Grants, No Reprogramming Seen

November 17, 1989